MedPath

浙江国镜药业有限公司

Ownership
-
Established
1997-06-01
Employees
-
Market Cap
-
Website
http://cn-guojing.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

96

NMPA:96

Drug Approvals

Macrogol Sodium Potassium Powder

Product Name
聚乙二醇钠钾散
Approval Number
国药准字H20253275
Approval Date
Jan 24, 2025
NMPA

Cefradine Capsules

Product Name
头孢拉定胶囊
Approval Number
国药准字H33021563
Approval Date
Sep 5, 2024
NMPA

Ganoderma Lucidum Capsule

Product Name
灵芝胶囊
Approval Number
国药准字Z33020704
Approval Date
Sep 3, 2024
NMPA

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H33020968
Approval Date
Aug 30, 2024
NMPA

Ranitidine Hydrochloride Capsules

Product Name
盐酸雷尼替丁胶囊
Approval Number
国药准字H33020919
Approval Date
Aug 30, 2024
NMPA

Cimetidine Capsules

Product Name
西咪替丁胶囊
Approval Number
国药准字H33020532
Approval Date
Aug 27, 2024
NMPA

Diclofenac Potassium Capsules

Product Name
得富卡
Approval Number
国药准字H20040652
Approval Date
Aug 27, 2024
NMPA

Cefradine Capsules

Product Name
头孢拉定胶囊
Approval Number
国药准字H33021090
Approval Date
Aug 15, 2024
NMPA

Polyethylene Glycol Electrolytes Powder(Ⅲ)

Product Name
复方聚乙二醇电解质散(Ⅲ)
Approval Number
国药准字H20244508
Approval Date
Jul 30, 2024
NMPA

精血补胶囊

Approval Number
国药准字Z20090810
Approval Date
Apr 17, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath